|
1
|
Natarajan Y, Kramer JR, Yu X, Li L, Thrift
AP, El-Serag HB and Kanwal F: risk of cirrhosis and hepatocellular
cancer in patients with non-alcoholic fatty liver disease and
normal liver enzymes. Hepatology. 72:1242–1252. 2020.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Sagnelli E, Macera M, Russo A, Coppola N
and Sagnelli C: Epidemiological and etiological variations in
hepatocellular carcinoma. Infection. 48:7–17. 2020.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Dimitroulis D, Damaskos C, Valsami S,
Davakis S, Garmpis N, Spartalis E, Athanasiou A, Moris D,
Sakellariou S, Kykalos S, et al: From diagnosis to treatment of
hepatocellular carcinoma: An epidemic problem for both developed
and developing world. World J Gastroenterol. 23:5282–5294.
2017.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Sun W, Wang Y, Cai M, Lin L, Chen X, Cao
Z, Zhu K and Shuai X: Codelivery of sorafenib and GPC3 siRNA with
PEI-modified liposomes for hepatoma therapy. Biomater Sci.
5:2468–2479. 2017.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Lu B, Yu GJ and Cheng M: Expression and
clinical significance of Snail and Claudin-3 in primary
hepatocellular carcinoma. Shandong Yiyao. 58:6–9. 2018.(In
Chinese).
|
|
6
|
Zhang H, Wu Y, Hu Y, Li X, Zhao M and Lv
Z: Targeted nanoparticle drug delivery system for the enhancement
of cancer immunotherapy. J Biomed Nanotechnol. 15:1839–1866.
2019.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Wu Y, Xu Z, Sun W, Yang Y, Jin H, Qiu L
and Chen J and Chen J: Co-responsive smart cyclodextrin-gated
mesoporous silica nanoparticles with ligand-receptor engagement for
anti-cancer treatment. Mater Sci Eng C. 103(109831)2019.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Lin A, Chen J, Liu Y, Deng S, Wu Z, Huang
Y and Ping Q: Preparation and evaluation of N-caproyl chitosan
nanoparticles surface modified with glycyrrhizin for hepatocyte
targeting. Drug Dev Ind Pharm. 35:1348–1355. 2009.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Sun Y, Dai C, Yin M, Lu J, Hu H and Chen
D: Hepatocellular carcinoma-targeted effect of configurations and
groups of glycyrrhetinic acid by evaluation of its
derivative-modified liposomes. Int J Nanomedicine. 13:1621–1632.
2018.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Yan T, Cheng J, Liu Z, Cheng F, Wei X,
Huang Y and He J: Acid-sensitive polymeric vector targeting to
hepatocarcinoma cells via glycyrrhetinic acid receptor-mediated
endocytosis. Mater Sci Eng C. 87:32–40. 2018.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Sakurai Y and Harashima H:
Hyaluronan-modified nanoparticles for tumor-targeting. Expert Opin
Drug Deliv. 16:915–936. 2019.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Tavianatou AG, Caon I, Franchi M,
Piperigkou Z, Galesso D and Karamanos NK: Hyaluronan: Molecular
size-dependent signaling and biological functions in inflammation
and cancer. FEBS J. 286:2883–2908. 2019.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Tirella A, Kloc-Muniak K, Good L, Ridden
J, Ashford M, Puri S and Tirelli N: CD44 targeted delivery of siRNA
by using HA-decorated nanotechnologies for KRAS silencing in cancer
treatment. Int J Pharm. 561:114–123. 2019.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Li W, Yan R, Liu Y, He C, Zhang X, Lu Y,
Khan MW, Xu C, Yang T and Xiang G: Co-delivery of Bmi1 small
interfering RNA with ursolic acid by folate receptor-targeted
cationic liposomes enhances anti-tumor activity of ursolic acid in
vitro and in vivo. Drug Deliv. 26:794–802. 2019.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Yu Y, Wang J, Kaul SC, Wadhwa R and Miyako
E: Folic acid receptor-mediated targeting enhances the
cytotoxicity, efficacy, and selectivity of withania somnifera leaf
extract: In vitro and in vivo evidence. Front Oncol.
9(602)2019.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Cai Y, Xu Y, Chan HF, Fang X, He C and
Chen M: Glycyrrhetinic acid mediated drug delivery carriers for
hepatocellular carcinoma therapy. Mol Pharm. 13:699–709.
2016.PubMed/NCBI View Article : Google Scholar
|
|
17
|
He ZY, Zheng X, Wu XH, Song XR, He G, Wu
WF, Yu S, Mao SJ and Wei YQ: Development of glycyrrhetinic
acid-modified stealth cationic liposomes for gene delivery. Int J
Pharm. 397:147–154. 2010.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Gao S, Wang J, Tian R, Wang G, Zhang L, Li
Y, Li L, Ma Q and Zhu L: Construction and evaluation of a targeted
hyaluronic acid nanoparticle/photosensitizer complex for cancer
photodynamic therapy. ACS Appl Mater Interfaces. 9:32509–32519.
2017.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Fang Z, Li X, Xu Z, Du F, Wang W, Shi R
and Gao D: Hyaluronic acid-modified mesoporous silica-coated
superparamagnetic Fe3O4 nanoparticles for
targeted drug delivery. Int J Nanomedicine. 14:5785–5797.
2019.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Tian G, Sun X, Bai J, Dong J, Zhang B, Gao
Z and Wu J: Doxorubicin loaded dual functional hyaluronic acid
nanoparticles: Preparation, characterization and antitumor efficacy
in vitro and in vivo. Mol Med Rep. 19:133–142. 2019.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Duan T, Xu Z, Sun F, Wang Y, Zhang J, Luo
C and Wang M: HPA aptamer functionalized paclitaxel-loaded PLGA
nanoparticles for enhanced anticancer therapy through targeted
effects and microenvironment modulation. Biomed Pharmacother.
117(109121)2019.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Handali S, Moghimipour E, Kouchak M,
Ramezani Z, Amini M, Angali KA, Saremy S, Dorkoosh FA and Rezaei M:
New folate receptor targeted nano liposomes for delivery of
5-fluorouracil to cancer cells: Strong implication for enhanced
potency and safety. Life Sci. 227:39–50. 2019.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Patel NR, Piroyan A, Ganta S, Morse AB,
Candiloro KM, Solon AL, Nack AH, Galati CA, Bora C, Maglaty MA, et
al: In vitro and in vivo evaluation of a novel folate-targeted
theranostic nanoemulsion of docetaxel for imaging and improved
anticancer activity against ovarian cancers. Cancer Biol Ther.
19:554–564. 2018.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Ren J, Chen Y, Song H, Chen L and Wang R:
Inhibition of ZEB1 reverses EMT and chemoresistance in
docetaxel-resistant human lung adenocarcinoma cell line. J Cell
Biochem. 114:1395–1403. 2013.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Cortes JE and Pazdur R: Docetaxel. J Clin
Oncol. 13:2643–2655. 1995.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Taxanes. In: LiverTox: Clinical and
Research Information on Drug-Induced Liver Injury, 2020.
|
|
27
|
Belderbos BP, Hussaarts KG, van Harten LJ,
Oomen-de Hoop E, de Bruijn P, Hamberg P, van Alphen RJ, Haberkorn
BC, Lolkema MP, de Wit R, et al: Effects of prednisone on docetaxel
pharmacokinetics in men with metastatic prostate cancer: A
randomized drug-drug interaction study. Br J Clin Pharmacol.
85:986–992. 2019.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Wu F, Zhang LX, Li XC, Jiang B, Zou SY,
Wang C, Mou WQ, Lian B, Wu JL, Yu WJ, et al: Preparation and
proliferation effect on hepatoma cells of adenine loaded
glycyrrhetinic acid modified hyaluronic acid nanoparticles.
Zhongguo Yaolixue Tongbao. 34:706–712. 2018.(In Chinese).
|
|
29
|
Kothari IR, Italiya KS, Sharma S, Mittal A
and Chitkara D: A rapid and precise liquid chromatographic method
for simultaneous determination of alpha lipoic acid and docetaxel
in lipid-based nanoformulations. J Chromatogr Sci. 56:888–894.
2018.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Lou YM and Huang ZB: Determination of the
related substances in docetaxel for drug materials by HPLC. Pharm
J. 23:41–44. 2011.
|
|
31
|
Cha L, Gu YH and Wang YL: Determination of
docetaxel drug substance by HPLC. J Hubei Univ Sci Technol. 31:3–5.
2017.
|
|
32
|
Stanković V, Mihailović V, Mitrović S and
Jurišić V: Protective and therapeutic possibility of medical herbs
for liver cirrhosis. Rom J Morphol Embryol. 58:723–729.
2017.PubMed/NCBI
|
|
33
|
Li X, Diao W, Xue H, Wu F, Wang W, Jiang
B, Bai J, Lian B, Feng W, Sun T, et al: Improved efficacy of
doxorubicin delivery by a novel dual-ligand-modified liposome in
hepatocellular carcinoma. Cancer Lett. 489:163–173. 2020.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Li ZP, Tian GX, Jiang H, Pan RY, Lian B,
Wang M, Gao ZQ, Zhang B, Wu JL, et al: Liver-targeting and
pH-sensitive sulfated hyaluronic acid mixed micelles for hepatoma
therapy. Int J Nanomedicine. 14:9437–9452. 2019.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Jurisic V, Srdic-Rajic T, Konjevic G,
Bogdanovic G and Colic M: TNF-α induced apoptosis is accompanied
with rapid CD30 and slower CD45 shedding from K-562 cells. J Membr
Biol. 239:115–122. 2011.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Wu F, Xue H, Li X, Diao W, Jiang B, Wang
W, Yu W, Bai J, Wang Y, Lian B, et al: Enhanced targeted delivery
of adenine to hepatocellular carcinoma using glycyrrhetinic
acid-functionalized nanoparticles in vivo and in vitro. Biomed
Pharmacother. 131(110682)2020.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Zhang L, Yao J, Zhou J, Wang T and Zhang
Q: Glycyrrhetinic acid-graft-hyaluronic acid conjugate as a carrier
for synergistic targeted delivery of antitumor drugs. Int J Pharm.
441:654–664. 2013.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Wu F, Li X, Jiang B, Yan J, Zhang Z, Qin
J, Yu W and Gao Z: Glycyrrhetinic acid functionalized nanoparticles
for drug delivery to liver cancer. J Biomed Nanotechnol.
14:1837–1852. 2018.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Aruffo A, Stamenkovic I, Melnick M,
Underhill CB and Seed B: CD44 is the principal cell surface
receptor for hyaluronate. Cell. 61:1303–1313. 1990.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Xiao H and Wang L: Effects of X-shaped
reduction-sensitive amphiphilic block copolymer on drug delivery.
Int J Nanomedicine. 10:5309–5325. 2015.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Doddapaneni R, Patel K, Chowdhury N and
Singh M: Noscapine chemosensitization enhances docetaxel anticancer
activity and nanocarrier uptake in triple negative breast cancer.
Exp Cell Res. 346:65–73. 2016.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Wang TH, Wang HS and Soong YK:
Paclitaxel-induced cell death: Where the cell cycle and apoptosis
come together. Cancer. 88:2619–2628. 2000.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Chen YN, Hsu SL, Liao MY, Liu YT, Lai CH,
Chen JF, Nguyen MT, Su YH, Chen ST and Wu LC: Ameliorative effect
of curcumin-encapsulated hyaluronic acid-PLA nanoparticles on
thioacetamide-induced murine hepatic fibrosis. Int J Environ Res
Public Health. 14(11)2016.PubMed/NCBI View Article : Google Scholar
|
